SCHEMBL70700

SCHEMBL70700

O=C(O)c1ccnc(-c2cc(C(=O)O)ccn2)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 10/20 0.78
KDM5C P41229 8/20 0.78
KDM4A O75164 6/20 0.78
KDM4E B2RXH2 6/20 0.78
KDM2A Q9Y2K7 5/20 0.78
KDM3A Q9Y4C1 5/20 0.78
KDM6B O15054 4/20 0.78
P4HA1 P13674 1/20 0.75
KDM5B Q9UGL1 7/20 0.70
KDM4B O94953 3/20 0.70
JMJD6 Q6NYC1 1/20 0.68
KDM5A P29375 4/20 0.65
TET3 O43151 1/20 0.65
BBOX1 O75936 1/20 0.65
ALDH1A1 P00352 1/20 0.65
MAPT P10636 1/20 0.65
ASPH Q12797 1/20 0.65
KDM4D Q6B0I6 1/20 0.65
TET2 Q6N021 1/20 0.65
ALKBH5 Q6P6C2 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29407015 1.00 KDM4C (0.78) KDM4CKDM5CKDM4AKDM4EKDM2A
SCHEMBL7034221 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A
Hydrochloric Acid SCHEMBL4802267 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A
Ammonia Solution, Strong SCHEMBL7159217 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A
SCHEMBL25221788 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A
SCHEMBL25273097 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A
SCHEMBL5670010 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A
SCHEMBL25220048 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A
SCHEMBL9626459 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A
Hydrochloric Acid SCHEMBL6018233 0.98 KDM4C (0.75) KDM4CKDM5CKDM4AKDM4EKDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12629667-B2 Di-nitrogen ligands for supported coordinated platinum hydrosilylation catalysts THE TRUSTEES OF INDIANA UNIVERSITY (US) 2026-05-19 US claimed
EP-4622945-A1 OLIGOMERISATION OF ALCOHOLS Terra Mater BV (BE) 2025-10-01 EP claimed
WO-2025132825-A1 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) 2025-06-26 WO claimed
US-12275003-B1 Carbon-supported copper manganite nanoparticles for biofuel production IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) 2025-04-15 US claimed
US-12206112-B2 Asymmetric metal complex as an active material of a flow battery THE UNIVERSITY OF AKRON (US) 2025-01-21 US claimed
US-20240327324-A1 METHOD FOR PRODUCING FATTY ALDEHYDES AND DERIVATIVES THEREOF FMC Agricultural Solutions A/S (DK) 2024-10-03 US claimed
WO-2024197225-A1 REDOX ACTIVE ANTIFOULING COATINGS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-09-26 WO claimed
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2024-09-26 US claimed
WO-2024172209-A1 DUAL-MODAL IRIDIUM-BASED SELF-INERT CHEMICAL SENSOR 고려대학교 산학협력단 2024-08-22 WO claimed
CN-116948169-B Method for rapidly synthesizing self-enhanced electrochemiluminescence probe in water phase based on polylysine and application thereof 华南师范大学 2024-06-28 CN claimed
EP-0750602-B1 PROCESS FOR PRODUCING ALCOHOLS AND/OR ALDEHYDES BASF AG (DE) 1998-08-19 EP claimed
WO-1997045767-A1 PHOTOELECTROCHEMICAL-ELECTROCHROMIC DEVICE MIDWEST RESEARCH INSTITUTE (US) 1997-12-04 WO claimed
EP-0588225-B1 Process for the preparation of aldehydes BASF AG (DE) 1997-06-18 EP claimed
WO-1997011955-A1 METHOD OF PREPARATION OF MONONUCLEAR RUTHENIUM COMPLEXES R.V.A. CAPITAL RISQUE S.A. (LU) 1997-04-03 WO claimed
US-5387719-A Preparation of aldehydes BASF AKTIENGESELLSCHAFT (DE) 1995-02-07 US claimed
EP-0588225-A2 Process for the preparation of aldehydes BASF Aktiengesellschaft (DE) 1994-03-23 EP claimed
US-5223634-A Molecular water oxidation catalyst THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1993-06-29 US claimed
EP-0266283-B1 PROCESS FOR THE PREPARATION OF A MIXTURE CONTAINING CYCLOHEXANOL AND CYCLOHEXANONE STARTING FROM CYCLOHEXANE RHONE-POULENC CHIMIE (FR) 1992-04-22 EP claimed
US-5001268-A Preparation of N-arylsubstituted amides RHONE-POULENC CHIMIE (FR) 1991-03-19 US claimed
US-4877903-A OXIDATION OF CYCLOHEXANE, DECOMPOSITION OF CYCLOHEXYL HYDROPEROXIDE RHONE-POULENC CHIMIE (FR) 1989-10-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12629667-B2 Di-nitrogen ligands for supported coordinated platinum hydrosilylation catalysts SCO2, HAO2, PDCD1LG2 KDM4C 2556/4885KDM5C 1602/4885KDM4A 2818/4885
US-12206112-B2 Asymmetric metal complex as an active material of a flow battery SLC39A14, AP2M1, SLC39A3 KDM4C 3320/4885KDM5C 3843/4885KDM4A 4285/4885
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME SOD1, SOD3, CAT KDM4C 4693/4885KDM5C 4733/4885KDM4A 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.